Antiviral Response and Resistance Analysis of Treatment-Naïve HCV Infected Subjects Receiving Single and Multiple Doses of GS-9190

Conference Reports for NATAP

AASLD
61th Annual Meeting of the American Association for the Study of Liver Diseases
Boston, MA, Hynes Convention Center
October 30-November 3, 2010


Antiviral Response and Resistance Analysis of Treatment-Naïve HCV Infected Subjects Receiving Single and Multiple Doses of GS-9190

	Reported by Jules Levin AASLD 2010 Nov 2 Boston J Harris1, A Bae1, S Sun2, E Svarovskaia2, M Miller2, and H Mo2 1Gilead Sciences, Inc, Durham, NC, USA; 2Gilead Sciences, Inc, Foster City, USA